{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:26:19Z","timestamp":1793755579825,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.vaccine.2025.127334","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T13:52:59Z","timestamp":1748699579000},"page":"127334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cardiac monitoring safety assessment framework for early phase group a streptococcal vaccine trials"],"prefix":"10.1016","volume":"60","author":[{"given":"James","family":"Marangou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Beaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Fulurija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Carapetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesl","family":"Z\u00fchlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Keech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2025.127334_bb0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group a streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127334_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11020179","article-title":"Recent advances in the rheumatic fever and rheumatic heart disease continuum","volume":"11","author":"Rwebembera","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2025.127334_bb0015","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"25","key":"10.1016\/j.vaccine.2025.127334_bb0020","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127334_bb0025","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and National Burden of rheumatic heart disease, 1990-2015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127334_bb0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41541-023-00609-x","article-title":"The Streptococcus pyogenes vaccine landscape","volume":"8","author":"Walkinshaw","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127334_bb0035","doi-asserted-by":"crossref","first-page":"2412745","DOI":"10.1080\/21505594.2024.2412745","article-title":"The intricate pathogenicity of group a Streptococcus: a comprehensive update","volume":"15","author":"Bergsten","year":"2024","journal-title":"Virulence"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127334_bb0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/am.16.3.509-518.1968","article-title":"Secondary and apparent primary antibody responses after group a streptococcal vaccination of 21 children","volume":"16","author":"Massell","year":"1968","journal-title":"Appl Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127334_bb0045","first-page":"1115","article-title":"Rheumatic fever following streptococcal vaccination","volume":"207","author":"Massell","year":"1969","journal-title":"Report of three cases Jama"},{"key":"10.1016\/j.vaccine.2025.127334_bb0050","series-title":"Revocation of status of specific products; group A Streptococcus. 70 Federal Register 72197","author":"Administration UFaD","year":"2005"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127334_bb0055","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group a Streptococcus vaccine in healthy adult volunteers","volume":"41","author":"McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127334_bb0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.292.6.709","article-title":"Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy AdultsPhase 1 trial","volume":"292","author":"Kotloff","year":"2004","journal-title":"JAMA"},{"issue":"46","key":"10.1016\/j.vaccine.2025.127334_bb0065","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group a streptococci","volume":"29","author":"Dale","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127334_bb0070","first-page":"14","volume":"71","year":"2018","journal-title":"World Health Assembly resolution"},{"key":"10.1016\/j.vaccine.2025.127334_bb0075","series-title":"2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","author":"WHO Bacterial Priority Pathogens List","year":"2024"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127334_bb0080","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/cid\/ciad311","article-title":"Safety of Streptococcus pyogenes vaccines: anticipating and overcoming challenges for clinical trials and post-marketing monitoring","volume":"77","author":"Asturias","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127334_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40268-024-00452-y","article-title":"Application of transthoracic echocardiography for cardiac safety evaluation in the clinical development process of vaccines against Streptococcus pyogenes","volume":"24","author":"Nakakana","year":"2024","journal-title":"Drugs R D"},{"key":"10.1016\/j.vaccine.2025.127334_bb0090","series-title":"Viral-Induced Enhanced Disease Illness Front Microbiol","first-page":"2991","volume":"9","author":"Smatti","year":"2018"},{"issue":"22","key":"10.1016\/j.vaccine.2025.127334_bb0095","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1016\/j.vaccine.2021.01.055","article-title":"Vaccine-associated enhanced disease: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"39","author":"Munoz","year":"2021","journal-title":"Vaccine"},{"issue":"Suppl 2(Suppl 2)","key":"10.1016\/j.vaccine.2025.127334_bb0100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13012-016-0452-0","article-title":"Proceedings of the 8th Annual Conference on the Science of Dissemination and Implementation\u202f: Washington, DC, USA. 14\u201315 December 2015","volume":"11","author":"Chambers","year":"2016","journal-title":"Implement Sci"},{"key":"10.1016\/j.vaccine.2025.127334_bb0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.12688\/wellcomeopenres.16849.1","article-title":"Vaccine-enhanced disease: case studies and ethical implications for research and public health","volume":"6","author":"Jamrozik","year":"2021","journal-title":"Wellcome Open Res"},{"issue":"13","key":"10.1016\/j.vaccine.2025.127334_bb0110","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/jama.2013.3010","article-title":"Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial","volume":"309","author":"Fowler","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2025.127334_bb0115","first-page":"13","article-title":"Vaccine-associated enhanced disease and pathogenic human coronaviruses","author":"Gartlan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127334_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100935","article-title":"Echocardiography for latent rheumatic heart disease in first degree relatives of children with acute rheumatic fever: implications for active case finding in family members","volume":"37","author":"Culliford-Semmens","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2025.127334_bb0125","article-title":"World heart federation guidelines for the echocardiographic diagnosis of rheumatic heart disease","volume":"2023","author":"Rwebembera","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127334_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5334\/gh.1327","article-title":"The echocardiographic diagnosis of rheumatic heart disease: a review of the performance of the world heart federation criteria 2012-2023","volume":"19","author":"Marangou","year":"2024","journal-title":"Glob Heart"},{"issue":"20","key":"10.1016\/j.vaccine.2025.127334_bb0135","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","article-title":"Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of doppler echocardiography: a scientific statement from the American Heart Association","volume":"131","author":"Gewitz","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.vaccine.2025.127334_bb0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijcard.2019.02.058","article-title":"The world heart federation criteria raise the threshold of diagnosis for mild rheumatic heart disease: three reviewers are better than one","volume":"291","author":"Culliford-Semmens","year":"2019","journal-title":"Int J Cardiol"},{"issue":"19","key":"10.1016\/j.vaccine.2025.127334_bb0145","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.113.003495","article-title":"What is normal? Echocardiographic findings in low-risk children living in a region with high rates of rheumatic heart disease","volume":"125","author":"Roberts","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127334_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127334_bb0155","doi-asserted-by":"crossref","first-page":"e983","DOI":"10.1016\/S2214-109X(24)00127-X","article-title":"Handheld echocardiography for the screening and diagnosis of rheumatic heart disease: a systematic review to inform WHO guidelines","volume":"12","author":"Provid\u00eancia","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127334_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127334_bb0165","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T17:42:28Z","timestamp":1762278148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25006310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":33,"alternative-id":["S0264410X25006310"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127334","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac monitoring safety assessment framework for early phase group a streptococcal vaccine trials","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127334"}}